Use of ivermectin and factors associated with the prevention and/or treatment of COVID-19: a cross-sectional online survey in the province of Chincha, Peru.
José Fernando Salvador-CarrilloLuz Campos-LozaDavid Guillen-CarbajalJorge OsadaAlejandra ZevallosJunior Smith Torres-RomanPublished in: F1000Research (2024)
Most people in Chincha used ivermectin during the second wave of the COVID-19 pandemic. The main factors associated with the use of ivermectin for the prevention/treatment of COVID-19 were age ≥50 years, having a technical education level, having had symptoms with negative/no diagnosis or positive diagnosis, and contact with people infected with SARS-CoV-2.